Company Search:
Advanced Search
Sponsored Links
Virbac Company Snapshot
Virbac operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Virbac with three other companies in this sector in France: Boiron SA (2017 sales of 617.54 million Euro [US$758.65 million] of which 50% was Non-Proprietary Homeopathic Medicines), Guerbet SA (812.40 million Euro [US$998.03 million] ), and Vetoquinol Sa (352.20 million Euro [US$432.68 million] ).

Sales Analysis. Virbac reported sales of 861.88 million Euro (US$1.06 billion) for the year ending December of 2017. This represents a decrease of 1.1% versus 2016, when the company's sales were 871.83 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for Virbac
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 127.00
(Figures in Euro)
1 Week 3.4%   13 Weeks 10.1%  
4 Weeks 6.7%   52 Weeks -5.3%  
Virbac Key Data:
  Ticker: VIRP Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 861,882,000
(Year Ending Jan 2018).
Employees: 4,852
  Currency: Euro Market Cap: 1,069,433,853
  Fiscal Yr Ends: December Shares Outstanding: 8,420,739
  Share Type: Actions Ordinaires Closely Held Shares: 4,274,299
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.